President of Global Health, Gates Foundation
| Authored | 5 |
| Substantive (25+ words) | 5 |
| Threads posted in | 3 |
| Distinct active days | 3 |
| Words authored | 745 |
| Received (incl. group broadcast) | 17 |
Received counts include every message sent to a channel this person belonged to. That measures presence, not participation.
4 sentences were extracted and attributed to this person. Most are not their own opinion. Reporting the total as “4 statements” would misrepresent them.
| Person | Medium | Msgs | Span |
|---|---|---|---|
| H. Clifford Lane | 29 | 2020-04-15 – 2020-04-15 | |
| Christa Bowles | 24 | 2020-03-31 – 2020-04-15 | |
| Patricia Conrad | 21 | 2020-04-15 – 2020-04-15 | |
| Mike Poole | 19 | 2020-04-15 – 2020-04-15 | |
| Penny Heaton | 17 | 2020-04-15 – 2020-04-15 | |
| Anthony S. Fauci | 7 | 2020-03-31 – 2021-07-26 | |
| Bill Gates | 4 | 2020-04-22 – 2021-07-26 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 | |
| Cliff | 1 | 2020-04-15 – 2020-04-15 |
Showing: own voice, substantive needs context quoted / not their view all
https://www.medrxiv.org/content/10.1101/2021.06.30.21259787v1.full.pdf Bill, Tony, this is the low (1/4) dose Moderna data which looks quite strong - I know Sette has a lot of additional data he presented over the weekend and I'm trying to get this from him.
Gates Package, p.1198 · original PDF · in context
Regulatory authorities (EMA and MHRA thus far) have agreed to immunogenicity phase 3 trials for the new vaccines coming along due to the inability to do standard phase 3 - in the 2 case I know of the endpoint will be NA superiority to the AZ vaccine.
Gates Package, p.1198 · original PDF · in context
By this standard we can be sure that Moderna low dose already meets this standard and of course going with a lower dose of an approved vaccine means that safety issues are off the table.
Gates Package, p.1198 · original PDF · in context
This is the only pathway to immediately double capacity from Moderna and even if only part of their supply was allocated to this it could mean a few hundred million additional vaccines in 2021.
Gates Package, p.1198 · original PDF · in context